Dunning BE - Search Results

1

Portal glucose infusion exerts an incretin effect associated with changes in pancreatic neural activity in conscious dogs.

Dunning BE, Moore MC, Ikeda T, Neal DW, Scott MF, Cherrington AD. Dunning BE, et al. Metabolism. 2002 Oct;51(10):1324-30. doi: 10.1053/meta.2002.34712. Metabolism. 2002. PMID: 12370854

2

Direct quantification of norepinephrine spillover and hormone output from the pancreas of the conscious dog.

Dunning BE, Scott MF, Neal DW, Cherrington AD. Dunning BE, et al. Am J Physiol. 1997 May;272(5 Pt 1):E746-55. doi: 10.1152/ajpendo.1997.272.5.E746. Am J Physiol. 1997. PMID: 9176171

3

Extraction of epinephrine and norepinephrine by the dog pancreas in vivo.

Ahrén B, Dunning BE, Havel PJ, Veith RC, Taborsky GJ Jr. Ahrén B, et al. Among authors: dunning be. Metabolism. 1988 Jan;37(1):68-73. doi: 10.1016/0026-0495(88)90031-5. Metabolism. 1988. PMID: 3336287 Free article.

4

Differential effects of short and long duration insulinotropic agents on meal-related glucose excursions.

de Souza CJ, Russo P, Lozito R, Dunning BE. de Souza CJ, et al. Among authors: dunning be. Diabetes Obes Metab. 2001 Apr;3(2):73-83. doi: 10.1046/j.1463-1326.2001.00114.x. Diabetes Obes Metab. 2001. PMID: 11298729

5

Neural control of islet function by norepinephrine and sympathetic neuropeptides.

Dunning BE, Taborsky GJ Jr. Dunning BE, et al. Adv Exp Med Biol. 1991;291:107-27. doi: 10.1007/978-1-4684-5931-9_10. Adv Exp Med Biol. 1991. PMID: 1927679 Review.

6

Glucose-dependent and glucose-sensitizing insulinotropic effect of nateglinide: comparison to sulfonylureas and repaglinide.

Hu S, Wang S, Dunning BE. Hu S, et al. Among authors: dunning be. Int J Exp Diabetes Res. 2001;2(1):63-72. doi: 10.1155/edr.2001.63. Int J Exp Diabetes Res. 2001. PMID: 12369728 Free PMC article.

7

The effect of food on the oral bioavailability and the pharmacodynamic actions of the insulinotropic agent nateglinide in healthy subjects.

Karara AH, Dunning BE, McLeod JF. Karara AH, et al. Among authors: dunning be. J Clin Pharmacol. 1999 Feb;39(2):172-9. doi: 10.1177/00912709922007606. J Clin Pharmacol. 1999. PMID: 11563410 Clinical Trial.

8

Lactate clamp: a method to measure lactate utilization in vivo.

Gao J, Islam MA, Brennan CM, Dunning BE, Foley JE. Gao J, et al. Among authors: dunning be. Am J Physiol. 1998 Oct;275(4):E729-33. doi: 10.1152/ajpendo.1998.275.4.E729. Am J Physiol. 1998. PMID: 9755094

9

Glucosamine inhibits glucokinase in vitro and produces a glucose-specific impairment of in vivo insulin secretion in rats.

Balkan B, Dunning BE. Balkan B, et al. Among authors: dunning be. Diabetes. 1994 Oct;43(10):1173-9. doi: 10.2337/diab.43.10.1173. Diabetes. 1994. PMID: 7926284

10

Pharmacodynamics of vildagliptin in patients with type 2 diabetes during OGTT.

He YL, Wang Y, Bullock JM, Deacon CF, Holst JJ, Dunning BE, Ligueros-Saylan M, Foley JE. He YL, et al. Among authors: dunning be. J Clin Pharmacol. 2007 May;47(5):633-41. doi: 10.1177/0091270006299137. J Clin Pharmacol. 2007. PMID: 17442688 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

63 results

Search Page

Filters